COMMITTED TO EXCELLENCE
Brown’s Pharma Holdings p.l.c. is pleased to announce the offer of €13,000,000 unsecured callable bonds maturing 2027-2031. The Bonds, having a nominal value of €100 per bond and issued at par, bear an interest rate of 3.9%. Calamatta Cuschieri Investment Services Ltd is acting as sponsor, manager and registrar for this bond issue. The proceeds of the Bond Issue shall be utilized to:
- acquire further pharmacy licenses,
- refurbish and equip pharmacies as well as invest in or fund other capital projects of the Group; invest in additional health services equipment,
- refinance existing debt; and
- fund the general corporate requirements of the Group.
Applications for subscriptions will be available to the general public from the 23rd of June 2021, with their listing on the main list of the Malta Stock Exchange scheduled for the 15th of July 2021.
Established in 1998 by Alexander Fenech and Robert Spiteri; pharmacists, long-time friends, and business partners, Brown’s has grown steadily over the past 23 years into the largest retail pharmacy group in Malta and now operates 21 outlets, conveniently located across Malta, and employs over 160 people.
The Group’s commitment to growth and improvement is also reflected through its acquisition of new licenses throughout the past 12 months. In early 2020 the Group merger with an existing chain of 5 pharmacies and continued its path towards expansion by acquiring Grognet Pharmacy, Mosta; Medical Plaza Pharmacy, San Gwann; and St Mary’s Pharmacy, Attard. Underlying this organic growth of the Group’s retail pharmacy portfolio is the Group’s core commitment to provide the best possible service and care to the community within which it operates.
This article does not intend to give any investment advice and the contents herein should not be construed as such.
The value of investments may increase as well as decrease and past performance is not an indication of future performance. Prospective investors wishing to apply for the Bonds are urged to read the Prospectus (available from the Company’s registered address or electronically on www.browns.pharmacy) and seek the advice of their financial intermediaries.
We are pleased to announce the offer of €13,000,000 unsecured callable bonds maturing 2027-2031, having a nominal value of €100 per bond and issued at par, bear an interest rate of 3.9%.